Skip to main content

Release not found

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Go to feed
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients · Novartis · PPN World